Stacey Meltzer Wasserman

Stacey Meltzer Wasserman has held various roles in the healthcare industry since 1992. Stacey began their career as an Account Director at IMS Health. Stacey then moved to Skila as a Senior Director of Business Development. After that, they served as Senior Director of Sales at Solucient LLC. Stacey then held the role of Director of Business Development at the Healthcare Division of Thomson Reuters. Following this, they were Senior Director of Sales at Activate Networks, Inc. Stacey then worked at GNS Healthcare from 2013 to 2019 in three roles, including Executive Director of Sales, Vice President of Business Development for the Pharmaceutical Market, and Senior Vice President of Business Development. In 2019, they became Chief Commercial Officer at Genuity Science. In 2021, they were appointed Chief Revenue Officer (CRO) at BrightInsight. Most recently, in 2022, they were appointed Chief Business Officer at Medisafe®.

Stacey Meltzer Wasserman received a BA in Biological Basis of Behavior from the University of Pennsylvania and an MBA in Strategic Marketing and Management from Rutgers University.